On Tuesday after Congress returned from recess, Rep. Dana Rohrbacher published a column in the Washington Post asking his conservative colleagues to support his budget amendment that would protect state-legal medical marijuana patients and providers from federal interference.
Not long ago, a supporter of mine, visiting from California, dropped by my Capitol office. A retired military officer and staunch conservative, he and I spent much of our conversation discussing the Republican agenda.
Finally, I drew a breath and asked him about an issue I feared might divide us: the liberalization of our marijuana laws, specifically medical marijuana reform, on which for years I had been leading the charge. What did he think about that controversial position?
“Dana,” he replied, “there are some things about me you don’t know.” He told me about his three sons, all of whom enlisted after 9/11.
Two of his sons returned from the battlefield whole and healthy. The third, however, came home suffering multiple seizures each day. His prospects were bleak.
His medical care fell under the total guidance of the Department of Veterans Affairs, whose doctors came under federal restraints regarding the treatments they could prescribe. (Among the treatments allowed were opioids.) Nothing worked.
Finally, a sympathetic doctor advised our young hero to see him in his private office, where he could prescribe medication derived from cannabis. The prescription worked. The seizures, for the most part, ceased.
“Dana,” said my friend, “I could hug you right now for what you’ve been doing, unknowingly, for my son.”
What had I been doing? With my Democrat friend Sam Farr, the now-retired California congressman, I wrote an amendment to spending bills that prohibits the federal government from prosecuting medical marijuana cases in states where voters have legalized such treatment. The amendment passed two consecutive years, the second time with a wider margin than the first, and has been extended through continuing resolutions and an omnibus spending bill.
Unfortunately, my longtime friend Jeff Sessions, the attorney general, has urged Congress to drop the amendment, now co-sponsored by Rep. Earl Blumenauer (D-Ore.). This, despite President Trump’s belief, made clear in his campaign and as president, that states alone should decide medical marijuana policies.
I should not need to remind our chief law enforcement officer nor my fellow Republicans that our system of federalism, also known as states’ rights, was designed to resolve just such a fractious issue. Our party still bears a blemish for wielding the “states’ rights” cudgel against civil rights. If we bury state autonomy in order to deny patients an alternative to opioids, and ominously federalize our police, our hypocrisy will deserve the American people’s contempt.
The amendment must be approved by the House Rules Committee in order to get a vote, where it will likely be approved for the FY 2018 federal budget. If it is not, a conference committee will need to choose the Senate version of the budget later this month. If one of these two options doesn’t happen, medical marijuana patients and providers will be open to federal prosecution once again.
We can’t let these protections expire. Please contact your lawmakers and ask them to support medical marijuana, and to ask their colleagues on the House Rules Committee to rule the Rohrabacher-Blumenauer amendment “in order.”